Nannetti, G., Parisi, S. G., Loregian, A., Andreis, S., Cavinato, S., Basso, M., . . . Palù, G. (2016). Daclatasvir plasma level and resistance selection in HIV patients with hepatitis C virus cirrhosis treated with daclatasvir, sofosbuvir, and ribavirin. International Journal of Infectious Diseases, 49, pp. 151-153. doi:10.1016/j.ijid.2016.06.020

Nannetti, Giulio, et al. "Daclatasvir Plasma Level and Resistance Selection in HIV Patients With Hepatitis C Virus Cirrhosis Treated With Daclatasvir, Sofosbuvir, and Ribavirin." International Journal of Infectious Diseases 49 (2016): 151-153.

Nannetti, Giulio, et al. "Daclatasvir Plasma Level and Resistance Selection in HIV Patients With Hepatitis C Virus Cirrhosis Treated With Daclatasvir, Sofosbuvir, and Ribavirin." International Journal of Infectious Diseases 49 (2016): 151-153.